Published in J Clin Microbiol on September 01, 1998
Detection of HPV by PCR-A Novel Step in the Prevention of Cancer Cervix. J Obstet Gynaecol India (2012) 0.75
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA (1991) 6.83
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Human papillomavirus testing in primary cervical screening. Lancet (1995) 5.09
The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA (1989) 4.23
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer (1995) 3.29
Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire. Br Med J (Clin Res Ed) (1984) 3.29
Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer (1994) 2.35
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol (1994) 2.00
Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res (1991) 1.99
Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis (1995) 1.94
Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol (1989) 1.80
New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst (1995) 1.71
The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol (1984) 1.54
Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Arch Fam Med (1993) 1.36
Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch Fam Med (1993) 1.35
Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol (1993) 1.28
Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer (1993) 1.24
Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol (1990) 1.18
Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype kits. Am J Clin Pathol (1990) 1.16
Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis (1995) 1.16
Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. Br J Cancer (1995) 1.07
Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05
Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis (1998) 0.96
Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am J Obstet Gynecol (1988) 0.94
Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV-DNA hybridization studies. Diagn Cytopathol (1987) 0.94
Interobserver variability of cervical smears with squamous-cell abnormalities: a Philadelphia study. Diagn Cytopathol (1994) 0.91
The current status of the Papanicolaou smear. CA Cancer J Clin (1995) 0.88
Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am J Obstet Gynecol (1990) 0.86
Prevalence of cervical dysplasia and HPV infection according to sexual behavior. Int J Cancer (1990) 0.86
Chronic disease reports: mortality trends--United States, 1979-1986. MMWR Morb Mortal Wkly Rep (1989) 0.83
The Papanicolaou smear and the cervigram. A preliminary report. J Reprod Med (1988) 0.82
Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study. J Fam Pract (1993) 0.82
Papanicolaou smear screening augmented by a magnified chemiluminescent exam. Int J Gynaecol Obstet (1993) 0.80
Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J Cancer Res Clin Oncol (1993) 0.80
The management of minor degrees of cervical dysplasia associated with the human papilloma virus. Yale J Biol Med (1992) 0.77
Cervical cancer control--Rhode Island. MMWR Morb Mortal Wkly Rep (1989) 0.77
An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol (1992) 0.76
Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol (1998) 3.51
Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract (2000) 3.38
Animal papillomaviruses. Microbiol Rev (1982) 3.19
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA (2001) 3.07
Teaching of human rights in US medical schools. JAMA (1996) 3.04
Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol (1986) 2.93
Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. Virology (1986) 2.83
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ (2001) 2.56
Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45
Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Inst (1980) 2.44
Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology (1981) 2.44
Latent papillomavirus and recurring genital warts. N Engl J Med (1985) 2.37
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol (1998) 2.22
Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract (1994) 2.19
Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2. J Clin Microbiol (1996) 2.11
Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res (1988) 2.10
Disqualifying criteria in a preparticipation sports evaluation. J Fam Pract (1995) 2.03
Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev (2000) 1.91
Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol (1995) 1.80
Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol (1989) 1.80
Physicians' attitudes and beliefs about deaf patients. J Am Board Fam Pract (1996) 1.79
Molecular cloning and nucleotide sequence of deer papillomavirus. J Virol (1985) 1.78
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol (2000) 1.78
Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer (1984) 1.78
Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure. Obstet Gynecol (1992) 1.70
Conserved polynucleotide sequences among the genomes of papillomaviruses. J Virol (1979) 1.70
Demonstration of two distinct classes of bovine papilloma virus. Virology (1978) 1.68
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer (1997) 1.65
The health status and health care utilization of deaf and hard-of-hearing persons. Arch Fam Med (1993) 1.65
Underwear: contamination by human papillomaviruses. Am J Obstet Gynecol (1990) 1.61
The effects of information and augmentative communication technique on attitudes toward nonspeaking individuals. J Speech Hear Res (1991) 1.53
A new type of papillomavirus associated with cancer of the uterine cervix. Virology (1987) 1.53
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol (1988) 1.52
A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol (1995) 1.50
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica (1999) 1.46
Bovine papilloma virus: presence of virus-specific DNA sequences in naturally occurring equine tumors. Proc Natl Acad Sci U S A (1977) 1.45
The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. Hum Pathol (1986) 1.45
Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol (2000) 1.44
Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners. Obstet Gynecol (1984) 1.41
The place of colposcopy and related systems in gynecologic practice and research. J Reprod Med (1988) 1.39
Genital human papillomavirus infection. Am Fam Physician (1991) 1.38
Quantitation of bovine papilloma viral DNA in viral-induced tumors. J Virol (1976) 1.37
Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Arch Fam Med (1993) 1.36
Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch Fam Med (1993) 1.35
A spectrum of bilateral squamous conjunctival tumors associated with human papillomavirus type 16. Ophthalmology (1991) 1.33
Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol (1986) 1.32
Comparison of the Directigen 1-2-3 Group A Strep Test with culture for detection of group A beta-hemolytic streptococci. J Clin Microbiol (1989) 1.28
An analysis of "long-term" follow-up results in patients with cervical intraepithelial neoplasia treated by cryotherapy. Am J Obstet Gynecol (1980) 1.28
Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol (1981) 1.27
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
Human papillomavirus (HPV) in condylomatous lesions of cervix. Am J Surg Pathol (1981) 1.25
Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol (1985) 1.24
Evidence for papillomavirus genus-specific antigens and DNA in laryngeal papilloma. Intervirology (1981) 1.22
Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol (1983) 1.22
Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother (2003) 1.22
Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res (1987) 1.21
Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol (1988) 1.18
Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol (1986) 1.16
Knowledge and attitudes about AIDS among deaf and hard of hearing persons. AIDS Care (1998) 1.15
Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation. J Reprod Med (2000) 1.15
The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology (1986) 1.12
Physical maps of bovine papillomavirus type 1 and type 2 genomes. J Virol (1979) 1.12
Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect (2000) 1.11
Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens. Intervirology (1986) 1.11
Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol (1979) 1.11
Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol (1986) 1.11
Physicians and exercise promotion. Am J Prev Med (1992) 1.10
Human papillomavirus type 52: a new virus associated with cervical neoplasia. J Gen Virol (1988) 1.08
Scanning electron microscopy of the human endometrial surface epithelium. Fertil Steril (1972) 1.08
Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst (1995) 1.07
Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol (2001) 1.07
Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear. Arch Fam Med (1996) 1.07
Extrachromosomal deer fibromavirus DNA in deer fibromas and virus-transformed mouse cells. Virology (1983) 1.07
Hybridization of bovine papilloma virus type 1 and type 2 DNA to DNA from virus-induced hamster tumors and naturally occurring equine tumors. Intervirology (1979) 1.04
Analyzing the values history: an evaluation of patient medical values and advance directives. J Clin Ethics (1993) 1.04
Evidence for an essential DNA component in the Scrapie agent. Nature (1978) 1.04
Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis (2001) 1.03
Evaluation of a peer education programme for female sex workers in Bali, Indonesia. Int J STD AIDS (2000) 1.02
Weight loss methods of high school wrestlers. Med Sci Sports Exerc (2001) 1.01
Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am J Obstet Gynecol (1999) 1.00
Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol (1987) 0.99
Patients' interpretation of qualitative probability statements. Arch Fam Med (1994) 0.99
Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol (2001) 0.98
A comparative ultrastuctural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus. Cancer (1971) 0.98
Comparison of 5-fluorouracil and CO2 laser for treatment of vaginal condylomata. Obstet Gynecol (1984) 0.98
Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol (1998) 0.97
Screening for cancer of the cervix. CMAJ (1991) 0.97
Detection of human papillomavirus DNA sequences in conjunctival papilloma. Am J Ophthalmol (1983) 0.97
Papillomavirus structural antigens in condyloma acuminatum of the male urethra. J Urol (1983) 0.96
Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer (1994) 0.96
Role of mono- and biarticular muscles in explosive movements. Int J Sports Med (1984) 0.95
Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol (1998) 0.95